39 results on '"Lv, Shuzheng"'
Search Results
2. Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial
3. Treatment of OSA Reduces the Risk of Repeat Revascularization After Percutaneous Coronary Intervention
4. Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention
5. Comparison of Long-Term (4-Year) Outcomes of Patients With Unprotected Left Main Coronary Artery Narrowing Treated With Drug-Eluting Stents Versus Coronary-Artery Bypass Grafting
6. The Long-Term Influence of Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Mild to Moderate Coronary Artery Lesions in a Chinese Population: A 7-Year Follow-Up Study
7. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention: a meta-analysis
8. Macrophage Inflammatory Protein-1β and Fibrinogen Are Synergistic Predictive Markers of Prognosis of Intermediate Coronary Artery Lesions
9. Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial
10. Percutaneous Treatment With Drug-Eluting Stent vs Bypass Surgery in Patients Suffering From Chronic Stable Angina With Multivessel Disease Involving Significant Proximal Stenosis in Left Anterior Descending Artery
11. Hypotonic contrast media is more toxic than isotonic contrast media on endothelial cells in vivo and in vitro
12. Gene- gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han population
13. SYNTAX Score-II Predicts Long-Term Mortality in Patients Who Underwent Left Main Percutaneous Coronary Intervention Treated With Second-Generation Drug-Eluting Stents
14. Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention
15. GW26-e3551 Plaque Thrombosis Are Reduced by Attenuating Plaque Inflammation with Pioglitazone and Are Evaluated by Fluorodeoxyglucose Positron Emission Tomography
16. Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model
17. Retraction Note: Impact of guidewire selection and operator expertise on radiation exposure in transradial angiography
18. Influence of Diabetes Mellitus on Long-Term Outcomes of Patients With Unprotected Left Main Coronary Artery Disease Treated With Either Drug-Eluting Stents or Coronary Artery Bypass Grafting
19. RETRACTED ARTICLE: Impact of guidewire selection and operator expertise on radiation exposure in transradial angiography
20. Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches
21. The Relationship Between Revascularization Extent and the Long-term Prognosis of Patients With Stable Angina Pectoris and Three-Vessel Disease Treated by Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents
22. Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
23. Hospital Quality Improvement Initiative for Patients With Acute Coronary Syndromes in China
24. The Use of a Modifi ed EuroSCORE to Evaluate Mortality Risk in Percutaneous Coronary Intervention
25. The impact of Valsartan on vascular endothelial cells in plaque with ApoE knockout mice
26. Relationship of depression, stress and endothelial function in stable angina patients
27. Prevalence and management of hypertension in patients with acute coronary syndrome vary with gender: Observations from the Chinese registry of acute coronary events (CRACE)
28. Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents
29. Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial
30. SHORT- AND LONG-TERM OUTCOMES OF CORONARY REVASCULARISATION IN PATIENTS WITH SEVERE LEFT VENTRICULAR DILATATION
31. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting
32. Long-Term (4-Year) Outcomes and Predictors of Adverse Cardiac Events After Sirolimus-Eluting Stent Implantation in Unprotected Left Main Coronary Artery
33. Twelve Months Clinical Outcome of Drug-Eluting Stents Implantation or Coronary Artery Bypass Surgery for the Treatment of Diabetic Patients with Multivessel Disease
34. GW25-e4416 Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: A meta-analysis of 61 studies including 6634 cases and 6393 controls
35. Effect of interactions between LEPR polymorphisms and smoking on coronary artery disease susceptibility.
36. Association of rs5368 and rs3917406 polymorphisms in E-selectin gene with premature coronary artery disease in Chinese Han population.
37. Comparison of long-term mortality of acute ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients after percutaneous coronary intervention.
38. Impact of guidewire selection and operator expertise on radiation exposure in transradial angiography.
39. The use of a modified EuroSCORE to evaluate mortality risk in percutaneous coronary intervention.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.